BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/12/2017 8:34:13 AM | Browse: 1028 | Download: 1187
 |
Received |
|
2017-10-13 02:23 |
|
Peer-Review Started |
|
2017-10-13 07:11 |
|
To Make the First Decision |
|
2017-11-08 03:09 |
|
Return for Revision |
|
2017-11-08 07:16 |
|
Revised |
|
2017-11-10 05:00 |
|
Second Decision |
|
2017-11-27 11:27 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2017-11-27 20:22 |
|
Articles in Press |
|
2017-11-27 20:22 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-12-05 09:02 |
|
Publish the Manuscript Online |
|
2017-12-12 08:34 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tatsuo Kanda, Kazushige Nirei, Naoki Matsumoto, Teruhisa Higuchi, Hitomi Nakamura, Hiroaki Yamagami, Shunichi Matsuoka and Mitsuhiko Moriyama |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| AMED |
|
| JSPS KAKENHI |
17K09404 |
|
| Corresponding Author |
Tatsuo Kanda, MD, PhD, Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-Kamicho, Itabashi-ku, Tokyo 173-8610, Japan. kandat-cib@umin.ac.jp |
| Key Words |
Direct-acting antiviral agent; Genotype 1b; Hepatitis C virus; Resistance-associated substitutions |
| Core Tip |
In this minireview, we focused on the retreatment of patients with treatment failure of direct-acting antiviral agents against hepatitis C virus genotype 1b (HCV GT1b) infection. We summarized the retreatment regimens for patients with failure of peginterferon and ribavirin plus HCV NS3/4A inhibitors and for those with failure of HCV NS5A inhibitors. We also demonstrated the resistance-associated substitutions of HCV NS5B nucleos(t)ide inhibitors. Attention should be paid when selecting both the initial treatment and retreat regimens to completely eradicate HCV infection. |
| Publish Date |
2017-12-12 08:34 |
| Citation |
Kanda T, Nirei K, Matsumoto N, Higuchi T, Nakamura H, Yamagami H, Matsuoka S, Moriyama M. Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b. World J Gastroenterol 2017; 23(46): 8120-8127 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i46/8120.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i46.8120 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
